ACCREDITED INVESTORS INC. – Revance Therapeutics, Inc. Transaction History
ACCREDITED INVESTORS INC. portfolio value:
$553,000
portfolio value
ACCREDITED INVESTORS INC. quarter portfolio value change:
+95.37%
quarter
Revance Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 270K | $27 | 20.49K | |
| Q2 2022 | share | 0.00% | 0 shares | -117K | $13.82 | 20.49K | |
| Q1 2022 | share | 0.00% | 0 shares | 66K | $19.5 | 20.49K | |
| Q4 2021 | share | 0.00% | 0 shares | -237K | $16.49 | 20.49K | |
| Q3 2021 | share | 0.00% | 0 shares | -36K | $27.86 | 20.49K | |
| Q2 2021 | share | 0.00% | 0 shares | 34K | $29.64 | 20.49K | |
| Q1 2021 | share | 0.00% | 0 shares | -8K | $27.95 | 20.49K | |
| Q4 2020 | share | Increase | 0.00% | 20.49K shares | 581K | $28.34 | 20.49K |